BioTek reMEDys Promotes Awareness and Education for Autoinflammatory Conditions

NEW CASTLE, Del.--(BUSINESS WIRE)--In honor of August being International Autoinflammatory Awareness Month, BioTek reMEDys, one of the nation’s largest independent specialty infusion pharmacies focused on rare diseases, is calling for enhanced education and awareness of these rare diseases and conditions.

Autoinflammatory diseases refer to problems with the innate immune system’s reactions. Immune cells target the body’s own healthy tissues by mistake, signaling the body to attack them. This can cause intense episodes of inflammation that result in such symptoms as fever, rash, or joint swelling. These diseases also carry the risk of amyloidosis, a potentially fatal buildup of a blood protein in vital organs. Autoinflammatory diseases are typically caused by changes in certain genes. This causes problems with proteins that are important in specific body functions.

BioTek reMEDys is urging its colleagues, patients, and the population at large to become more aware and help drive education regarding these conditions.

“Because many autoimmune conditions are statistically rare, they can often be misdiagnosed and we hope to help shine a light on the importance of education about these conditions,” said Andrew Babb, PharmD, BioTek reMEDys’ Pharmacist in Charge. “Treatments for autoinflammatory diseases are typically very effective and can involve medications that reduce inflammation or suppress the immune system to alleviate symptoms. The diagnosis and treatment of autoimmune disorders can be very complex, requiring knowledgeable and dedicated staff to help provide guidance and counseling to patients during a challenging time in their lives. At BioTek reMEDys we are proud to be one of the few organizations today that serves this specific community of patients through our specialty infusion services.”

BioTek reMEDys provides therapy-specific patient education materials and its National Customer Support Center is available 24 hours a day, seven days a week to help HD patients and their loved ones manage critical aspects of care. By servicing very specific disease states such autoinflammatory conditions, BioTek reMEDys’ expert team can maintain its focus on patient care – making sure that dosages and treatments are appropriate.

Additional information and news about autoinflammatory diseases can be found at International Society of Systemic Auto-inflammatory Diseases (ISSAID) website, issaid.org.

Founded in 2011, BioTek reMEDys, based in New Castle, DE, has become one of the nation’s largest independent infusion pharmacies focused on home infusion. Chai Gadde opened the pharmacy to meet the specific needs of patients who require specialty medications. BioTek reMEDys and its affiliates are now licensed to operate in all 50 states. For information visit www.biotekrx.com.